🔗 Permalink

Inventor profile of:

Werner Scheuer

City:

Penzberg

Country:

Germany

Published Applications:

50

Last publication date:

2023-07-20

Top Assignees for applications by Werner Scheuer

The entities that hold a legal rights for patent applications filed by inventor Scheuer Werner:

HOFFMANN-LA ROCHE INC. 25 Little Falls, NJ United States
Hoffmann-La Roche Inc. 16 Nutley, NJ United States
Hoffman-La Roche Inc. 2 Little Falls, NJ United States
Hoffman-La Roche. Inc. 1 Nutley, NJ United States
F. HOFFMAN-LA ROCHE AG 1 Basel, Switzerland
The United States of America, as represented by the Secretary, Department of Health and Human Services 1 Washington, DC United States

Recent patent applications by Scheuer Werner

Werner Scheuer from Penzberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-07-20

US20230227543A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#2 | 2021-12-16

US20210388071A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#3 | 2021-02-18

US20210047394A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#4 | 2020-09-17

US20200291131A1

Chemistry; metallurgy

Bispecific HER2 antibodies and methods of use

#5 | 2020-08-20

US20200262904A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#6 | 2020-06-11

US20200181280A1

Chemistry; metallurgy

MODIFIED PSEUDOMONAS EXOTOXIN A

#7 | 2019-10-03

US20190298861A1

Human necessities

IN VIVO SELECTION OF THERAPEUTICALLY ACTIVE ANTIBODIES

#8 | 2018-10-04

US20180282404A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#9 | 2018-09-06

US20180251536A1

Chemistry; metallurgy

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

#10 | 2017-12-28

US20170369566A1

Chemistry; metallurgy

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#11 | 2017-08-24

US20170240626A1

Chemistry; metallurgy

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

#12 | 2017-08-24

US20170239353A1

Human necessities

TUMOR THERAPY WITH AN ANTIBODY FOR VASCULAR ENDOTHELIAL GROWTH FACTOR AND AN ANTIBODY FOR HUMAN EPITHELIAL GROWTH FACTOR RECEPTOR TYPE 2

#13 | 2017-02-23

US20170051072A1

Chemistry; metallurgy

MODIFIED PSEUDOMONAS EXOTOXIN A

#14 | 2017-02-02

US20170029529A1

Chemistry; metallurgy

Bispecific HER2 antibodies and methods of use

#15 | 2017-02-02

US20170029493A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#16 | 2016-01-14

US20160009823A1

Chemistry; metallurgy

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

#17 | 2015-10-08

US20150284457A1

Chemistry; metallurgy

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

#18 | 2015-10-08

US20150283238A1

Human necessities

Tumor Therapy with an Antibody for Vascular Endothelial Growth Factor and an Antibody for Human Epithelial Growth Factor Receptor Type 2

#19 | 2015-08-27

US20150239969A1

Chemistry; metallurgy

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

#20 | 2015-07-09

US20150191535A1

Chemistry; metallurgy

BISPECIFIC, BIVALENT ANTI-VEGF/ANTI-ANG2 ANTIBODIES

#21 | 2015-04-09

US20150099707A1

Chemistry; metallurgy

Modified exotoxin A

#22 | 2015-01-01

US20150004166A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#23 | 2014-04-10

US20140099264A1

Human necessities

MEANS AND METHODS FOR IN VIVO TESTING OF THERAPEUTIC ANTIBODIES

#24 | 2014-04-03

US20140093458A1

Human necessities

IN VIVO SELECTION OF THERAPEUTICALLY ACTIVE ANTIBODIES

#25 | 2014-03-06

US20140065707A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#26 | 2014-03-06

US20140065151A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#27 | 2013-12-05

US20130323180A1

Human necessities

Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label

#28 | 2013-09-12

US20130236906A1

DIAGNOSTIC METHOD FOR THE DETECTION OF CELLS EX VIVO

#29 | 2013-07-18

US20130183292A1

Human necessities

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

#30 | 2013-06-20

US20130156789A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#31 | 2012-12-20

US20120321627A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#32 | 2012-11-08

US20120282280A1

Chemistry; metallurgy

Bi-specific digoxigenin binding antibodies

#33 | 2012-10-25

US20120269723A1

Chemistry; metallurgy

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

#34 | 2012-09-13

US20120230918A1

NON-INVASIVE IN VIVO OPTICAL IMAGING METHOD

#35 | 2012-09-06

US20120226119A1

Human necessities

VIVO TUMOR VASCULATURE IMAGING

#36 | 2012-06-07

US20120142091A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#37 | 2012-06-07

US20120141500A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#38 | 2011-09-29

US20110236388A1

Chemistry; metallurgy

Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies

#39 | 2011-09-15

US20110223159A1

Chemistry; metallurgy

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

#40 | 2011-07-07

US20110165082A1

Human necessities

Method for determining the anti-tumor efficacy of monoclonal antibodies

#41 | 2011-03-17

US20110064736A1

Human necessities

Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2

#42 | 2011-02-03

US20110027190A1

Human necessities

Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label

#43 | 2010-11-11

US20100285010A1

Chemistry; metallurgy

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

#44 | 2010-06-24

US20100159587A1

Chemistry; metallurgy

Antibodies against human angiopoietin 2

#45 | 2010-05-06

US20100111967A1

Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies

#46 | 2008-05-01

US20080102069A1

Chemistry; metallurgy

TUMOR THERAPY WITH A COMBINATION OF ANTI-HER2 ANTIBODIES

#47 | 2008-02-28

US20080050385A1

Chemistry; metallurgy

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

#48 | 2007-09-27

US20070224203A1

Human necessities

Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2

#49 | 2007-01-11

US20070009976A1

Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody

#50 | 2005-07-14

US20050153416A1

Chemistry; metallurgy

Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof

InventorID:

298732 ⎘